The overall goal of this ICMIC is to develop and use advanced imaging approaches to gain in-depth knowledge of critical cancer targets, pathways and cellular function. This information will ultimately be used to identify new therapeutic points of attack and to guide clinical trials with prominent drug development candidates. To this end, we have brought together a multi-disciplinary team of basic and clinical investigators who will function as a single intellectual unit in the development of imaging approaches for targeted therapeutic applications. Project 1 (Weissleder) will focus on the development of effective new imaging agents for intracellular cancer targets using a novel bioorthogonal chemistry. Project 2 (Mazitschek, Clardy) will develop and test imaging approaches for different histone deacetylase (HDAC), enzymes associated with epigenetic gene regulation and which are strongly implicated in cancer. Project 3 (Lin, Scadden) will harness vanguard technologies to image and better understand the clonal fates of tumor cells and their associated stromal cells. Project 4 (Pittet) will investigate tumor-associated immune responses, and the effects of therapies on these responses. There will be two Developmental Fund Projects per year, the aims of which will be to attract new investigators to the P50, stimulate creative high-impact research, rapidly test new ideas, and fund promising collaborative work. The highly effective Career Development Program will continue to provide new junior investigators with the necessary multidisciplinary skills for a successful research career in cancer imaging. The above projects and programs will be facilitated by state-of-the art, highly innovative Specialized Resources in Chemistry (Hilderbrand), and in Mouse Imaging and Analysis (Nahrendorf). Fiscal management and oversight, as well as IT and statistical support will be provided by an Administration, Statistics and IT Core (Weissleder). Together, these ICMIC components will work synergistically to a) incorporate molecular imaging into pioneering cancer research at Harvard/MGH, and b) encourage the translation of molecular imaging to the practice of cancer diagnosis, management and therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA086355-14
Application #
8535532
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (M1))
Program Officer
Menkens, Anne E
Project Start
2000-08-09
Project End
2016-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
14
Fiscal Year
2013
Total Cost
$1,449,218
Indirect Cost
$612,885
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Keliher, Edmund J; Klubnick, Jenna A; Reiner, Thomas et al. (2014) Efficient acid-catalyzed (18) F/(19) F fluoride exchange of BODIPY dyes. ChemMedChem 9:1368-73
Dubach, J Matthew; Vinegoni, Claudio; Weissleder, Ralph (2014) Steady state anisotropy two-photon microscopy resolves multiple, spectrally similar fluorophores, enabling in vivo multilabel imaging. Opt Lett 39:4482-5
Pittet, Mikael J; Nahrendorf, Matthias; Swirski, Filip K (2014) The journey from stem cell to macrophage. Ann N Y Acad Sci 1319:1-18
Thurber, Greg M; Reiner, Thomas; Yang, Katherine S et al. (2014) Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors. Mol Cancer Ther 13:986-95
Courtis, Alexandra M; Santos, Sofia A; Guan, Yinghua et al. (2014) Monoalkoxy BODIPYs--a fluorophore class for bioimaging. Bioconjug Chem 25:1043-51
Hideshima, T; Mazitschek, R; Santo, L et al. (2014) Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors. Leukemia 28:457-60
Kim, Eunha; Yang, Katherine S; Giedt, Randy J et al. (2014) Red Si-rhodamine drug conjugates enable imaging in GFP cells. Chem Commun (Camb) 50:4504-7
Dubach, J M; Vinegoni, C; Mazitschek, R et al. (2014) In vivo imaging of specific drug-target binding at subcellular resolution. Nat Commun 5:3946
Turetsky, Anna; Kim, Eunha; Kohler, Rainer H et al. (2014) Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor. Sci Rep 4:4782
Aceto, Nicola; Bardia, Aditya; Miyamoto, David T et al. (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158:1110-22

Showing the most recent 10 out of 266 publications